00555nas a2200205   4500000000100000000000100001008004100002260001500043653001500058653002300073653001500096653001500111653001600126100002000142245009400162856006000256300001200316490000700328022001400335       2026                            d  c2026-04-1410aantibodies10aascites antibodies10amonoclonal10apolyclonal10arecombinant1 aKatherine Groff00aIncreasing the use of sequence-defined antibodies: Practical solutions for common targets  uhttps://www.altex.org/index.php/altex/article/view/3125  a347-3520 v43  a1868-8551